Troubles fonctionnels

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Estomac / intestins » Troubles fonctionnels

10. Juin 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

MII (maladie de Crohn/colite)

Troubles fonctionnels

Écriture:

Page 1 de 477


	Articles 1 - 20 / 9536

	Comment on "Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis". J Gastroenterol Hepatol Zhu J, Qiu X, Ma R. PMID: 42252522 [PubMed - as supplied by publisher]
	Gut microbiota signatures differentiate trajectory-defined response phenotypes and predict self-management outcomes in irritable bowel syndrome. medRxiv Chen J, Li A, Wu W, Xu W, Zhao T, Starkweather AR, Rodriguez L, Chen MH, Cong XS. PMID: 42238447 [PubMed]
	Reassessing Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Comparative Study of Diagnostic Guidelines and Their Clinical Relevance. J Gastroenterol Hepatol Loh AJC, Loo QY, Ng AK, Khoo XH, Siah KT, Abdul Majid H, Mahadeva S, Chuah KH. PMID: 42235989 [PubMed - as supplied by publisher]
	Multi-omics mendelian randomization integrating GWAS and eQTL data revealed potential drug target for irritable bowel syndrome. Front Genet Ke H, Chen W, Zhang Q, Liu Z, Wei P, Li L, Yu H, Huang D, Lan C, Xu N, Pi L, Song K. PMID: 42232515 [PubMed]
	Bodily Maps of Emotions in Irritable Bowel Syndrome: A Case-Control Study. Neurogastroenterol Motil Dens K, Van Den Houte M, Tack J, Toelen J, Dupont P, Van Oudenhove L. PMID: 42226507 [PubMed - indexed for MEDLINE]
	Comparative Effectiveness of Hangeshashinto and Ramosetron for the Treatment of Irritable Bowel Syndrome with Diarrhea. Digestion Nishida K, Hirata Y, Murano M, Mitooka H, Sugishima S, Nakazawa K, Koshiba R, Kakimoto K, Miyazaki T, Nakamura S, Nishikawa H. PMID: 42224387 [PubMed - as supplied by publisher]
	Feasibility and efficacy of fecal microbiota transplantation in adolescents with refractory irritable bowel syndrome: A randomized clinical pilot trial. J Pediatr Gastroenterol Nutr de Bruijn CMA, Oorthuys AOJ, Zeevenhooven J, Davids M, Levels JHM, Vlieger AM, Herrema H, Nieuwdorp M, Benninga MA. PMID: 42220281 [PubMed - as supplied by publisher]
	Dietary habits and their association with irritable bowel syndrome among the public population in Saudi Arabia: a multicenter based study. Front Public Health Qalawa SAA, Elbqry MG, Elmansy FM, Almunif AT, Alharbi BF, Alharbi RJ, Alharbi JA, Alharbi KM, Almuhaysin SA, Almutairi ST, Albashir WM. PMID: 42211719 [PubMed - indexed for MEDLINE]
	Efficacy and safety of modified Gwakjeongtang (herbal medicine) for diarrhea-predominant irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial. Integr Med Res Choi Y, Ha NY, Kim AR, Kwon O, Jeong H, Yuk HJ, Park KS, Kim J, Kim J, Kim H. PMID: 42211410 [PubMed]
	Characterizing Abdominal Pain and Irritable Bowel Syndrome Among Individuals With Cirrhosis: Results of a Nationwide Survey. Gastro Hep Adv Deng LX, Almario CV, Lai JC, Spiegel BMR, Rubin JB. PMID: 42205170 [PubMed]
	Application of neuromodulation techniques in irritable bowel syndrome. Front Neurosci Zhang Y, Gao L, Zhang X, Sun W, Wang M, Zhang T, Wang X. PMID: 42200039 [PubMed]
	Gut Microbiota in Irritable Bowel Syndrome and Inflammatory Bowel Disease: Differences in Pathophysiology, Biomarkers, and Treatment Implications. Pharmaceuticals (Basel) Pastras P, Aggeletopoulou I, Psalti V, Triantos C. PMID: 42198457 [PubMed]
	Effects of Î³-Aminobutyric Acid (GABA) Supplementation on Symptoms, Quality of Life, Intestinal Permeability, Systemic Inflammation and Gut Microbiota in Patients with IBS-D: A Randomized, Double Blind, Placebo-Controlled, Crossover Pilot Study. Nutrients Lambiase C, Cancelli L, Tedeschi R, Grosso A, Rettura F, Salemmo R, Bottari A, Filippini F, Salvadori S, Valdiserra G, Campigli L, Antonioli L, Fornai M, de Bortoli N, Bellini M. PMID: 42197028 [PubMed - indexed for MEDLINE]
	Long-Term Risk of Parkinson's Disease Following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study. Healthcare (Basel) Bae Y, Seo S, Jeon SR, Dong JJ, Lee SW, Jung H. PMID: 42194421 [PubMed]
	Consensus on Irritable Bowel Syndrome-like Symptoms in Inflammatory Bowel Disease: A Step Toward Advancing Patient-Centered Care. Gastroenterology Burisch J, Marsiglio M, Keszthelyi D. PMID: 42191045 [PubMed - as supplied by publisher]
	Research Progress on the Role of Lactobacillus reuteri in Irritable Bowel Syndrome: A Review. Biology (Basel) Zhen J, Zhou Z, Zhu R, Kuang M, Huang P. PMID: 42187770 [PubMed]
	Cardiometabolic Burden of Irritable Bowel Syndrome: A Case-Control Analysis of Metabolic Syndrome Clustering. J Epidemiol Glob Health Abdelaziz MN, Abdallah O, Bshar AM, Alqenawy M, Elkasabi HG, Mansour NF, Mahmoud T, Abdelaziz MME, Moustafa ARA, Almenshawy A, Elmorsy BZ. PMID: 42185575 [PubMed - indexed for MEDLINE]
	Deciphering the multi-target mechanism of Magnolia officinalis in irritable bowel syndrome with diarrhea: A combined network pharmacology, machine learning, and in vivo validation study. Biochem Biophys Res Commun Wang X, Wei Y, Wang M, Zhang Y, Liu L, Ma X, Gao L, Ji H. PMID: 42176387 [PubMed - indexed for MEDLINE]
	Bifidobacterium breve Promotes the Pathogenesis of IBS by Downregulating the Expression of Ferroptosis-Related Molecule ERBB1: A Mendelian Randomization Mediation Analysis. Hum Mutat Mo L, Wu Y, Zhou Y, He Y, Wei L, Zhou C, Cai S, Yuan J. PMID: 42170302 [PubMed - indexed for MEDLINE]
	Duloxetine as a gut-brain axis modulator in irritable bowel syndrome: neuroimmune, microbiota, and pharmacogenomic perspectives. Naunyn Schmiedebergs Arch Pharmacol Rejili M, Mustafa AM, Al-Kuraishy HM, Hussein NR, Al-Maiahy TJ, Al-Gareeb AI, Albuhadily AK, Batiha GE. PMID: 42168405 [PubMed - as supplied by publisher]

Articles 1 - 20 / 9536

Page 1 de 477



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité